# DNAJB2

## Overview
DNAJB2 is a gene that encodes the protein DnaJ heat shock protein family (Hsp40) member B2, which is a molecular chaperone involved in maintaining protein homeostasis within cells. As a member of the Hsp40 family, DNAJB2 plays a crucial role in protein folding, degradation, and stress response, particularly in the cytoplasm where it prevents protein aggregation and assists in the refolding of misfolded proteins. This function is vital for neuronal health, as protein misfolding and aggregation are common in neurodegenerative diseases. DNAJB2 is classified as a Type II J protein, characterized by the absence of a cysteine-rich zinc finger domain and the presence of a glycine/phenylalanine-rich region and a C-terminal domain for client protein binding. Mutations in the DNAJB2 gene are linked to several neuromuscular disorders, including Charcot-Marie-Tooth disease and distal spinal muscular atrophy, underscoring its importance in maintaining neuronal integrity and function (Dilliott2022DnaJC7; Sarparanta2020Neuromuscular).

## Structure
DNAJB2 is a member of the Hsp40 family of co-chaperones, characterized by the presence of a J-domain, which is crucial for stimulating the ATPase activity of Hsp70. This domain is approximately 70 amino acids long and consists of three alpha-helices with a conserved HPD motif essential for interaction with Hsp70 (Dilliott2022DnaJC7). DNAJB2 belongs to the Type II class of J proteins, which lack the cysteine-rich zinc finger domain found in Type I proteins but include a glycine/phenylalanine-rich region and a C-terminal domain involved in client protein binding (Dilliott2022DnaJC7).

DNAJB2 is associated with neurodegenerative diseases, such as Charcot-Marie-Tooth disease and distal spinal muscular atrophy, due to its role in reducing protein aggregation and improving motor neuron survival (Dilliott2022DnaJC7). The protein may undergo post-translational modifications like phosphorylation, which can influence its function and interactions. DNAJB2 also has splice variants, which can affect its function and localization, although specific details on these variants are not provided in the context. The protein's structure and function are integral to its role in protein quality control and stress response mechanisms.

## Function
DNAJB2, a member of the Hsp40 family, functions as a molecular chaperone involved in protein quality control within cells. It plays a critical role in protein folding, degradation, and stress response, helping to maintain cellular protein homeostasis. DNAJB2 is particularly active in the cytoplasm, where it assists in the prevention of protein aggregation and facilitates the refolding of misfolded proteins. This activity is crucial for maintaining neuronal health and function, as protein misfolding and aggregation are common features in neurodegenerative diseases (Dilliott2022DnaJC7).

DNAJB2 is part of the Type II J proteins, which are characterized by the absence of a cysteine-rich region found in Type I J proteins. Instead, they have a glycine/phenylalanine-rich region that links to the C-terminal domain, making them well-suited for aiding in protein disaggregation (Dilliott2022DnaJC7). The protein's involvement in cellular processes is underscored by its association with neurological phenotypes, such as Charcot-Marie-Tooth disease and distal spinal muscular atrophy, highlighting its importance in maintaining neuronal integrity and function (Dilliott2022DnaJC7).

## Clinical Significance
Mutations in the DNAJB2 gene are associated with several neuromuscular diseases, including distal hereditary motor neuropathy (dHMN) and Charcot-Marie-Tooth disease type 2 (CMT2). These conditions are characterized by muscle weakness and atrophy, primarily affecting the distal limbs. DNAJB2 mutations often follow an autosomal recessive inheritance pattern, with specific mutations such as c.352+1G>A and c.229+1G>A leading to intron retention and reduced protein expression (Lupo2016Chaperonopathies:; Sarparanta2020Neuromuscular). A large deletion involving the first four exons of DNAJB2 has been linked to spinal muscular atrophy and juvenile parkinsonism, expanding the clinical spectrum of DNAJB2-related neuropathies (Sarparanta2020Neuromuscular).

Patients with DNAJB2 mutations may also exhibit central nervous system symptoms, such as early-onset parkinsonism and cerebellar ataxia, although the direct link to DNAJB2 mutations is not fully established (Lupo2016Chaperonopathies:; Sarparanta2020Neuromuscular). The p.Y5C missense mutation is speculated to destabilize the J domain, contributing to a loss-of-function mechanism (Sarparanta2020Neuromuscular). These mutations impair protein quality control and trafficking, potentially leading to the accumulation of misfolded proteins and subsequent neurodegeneration (Sarparanta2020Neuromuscular).

## Interactions



## References


[1. (Lupo2016Chaperonopathies:) Vincenzo Lupo, Carmen Aguado, Erwin Knecht, and Carmen Espin√≥s. Chaperonopathies: spotlight on hereditary motor neuropathies. Frontiers in Molecular Biosciences, December 2016. URL: http://dx.doi.org/10.3389/fmolb.2016.00081, doi:10.3389/fmolb.2016.00081. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fmolb.2016.00081)

[2. (Dilliott2022DnaJC7) Allison A. Dilliott, Catherine M. Andary, Meaghan Stoltz, Andrey A. Petropavlovskiy, Sali M. K. Farhan, and Martin L. Duennwald. Dnajc7 in amyotrophic lateral sclerosis. International Journal of Molecular Sciences, 23(8):4076, April 2022. URL: http://dx.doi.org/10.3390/ijms23084076, doi:10.3390/ijms23084076. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms23084076)

[3. (Sarparanta2020Neuromuscular) Jaakko Sarparanta, Per Harald Jonson, Sabita Kawan, and Bjarne Udd. Neuromuscular diseases due to chaperone mutations: a review and some new results. International Journal of Molecular Sciences, 21(4):1409, February 2020. URL: http://dx.doi.org/10.3390/ijms21041409, doi:10.3390/ijms21041409. This article has 61 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms21041409)